Effect of telomerase activation on biological behaviors of neural stem cells in rats with hypoxic-ischemic insults
MENG Jun-Jie, LI Shi-Ping, ZHAO Feng-Yan, TONG Yu, MU De-Zhi, QU Yi
Department of Pediatrics, West China Second University Hospital, Sichuan University/Key Laboratory of Birth Defects and Related Diseases of Women and Children, Ministry of Education/Key Laboratory of Development and Related Diseases of Women and Children, Chengdu 610041, China
Abstract Objective To investigate the effect of telomerase activation on biological behaviors of neural stem cells after hypoxic-ischemic insults. Methods The neural stem cells passaged in vitro were divided into four groups: control, oxygen-glucose deprivation (OGD), OGD+cycloastragenol (CAG) high concentration (final concentration of 25 μM), and OGD+CAG low concentration (final concentration of 10 μM). The latter three groups were subjected to OGD. Telomerase reverse transcriptase (TERT) expression level was evaluated by Western blot. Telomerase activity was detected by telomerase repeat amplification protocol (TRAP). Cell number and neural sphere diameter were measured under a microscope. The activity of lactate dehydrogenase (LDH) was examined by chemiluminescence. Cell proliferation rate and apoptosis were detected by flow cytometry. Results After OGD insults, obvious injury of neural stem cells was observed, including less cell number, smaller neural sphere, more dead cells, lower proliferation rate and decreased survival rate. In CAG-treated groups, there were higher TERT expression level and telomerase activity compared with the control group (P < 0.05). In comparison with the OGD group, CAG treatment attenuated cell loss (P < 0.05) and neural sphere diameter decrease (P < 0.05), promoted cell proliferation (P < 0.05), and increased cell survival rate (P < 0.05). Low and high concentrations of CAG had similar effects on proliferation and survival of neural stem cells (P > 0.05). In the normal cultural condition, CAG treatment also enhanced TERT expression (P < 0.05) and increased cell numbers (P < 0.05) and neural sphere diameter (P < 0.05) compared with the control group. Conclusions Telomerase activation can promote the proliferation and improve survival of neural stem cells under the state of hypoxic-ischemic insults, suggesting telomerase activators might be potential agents for the therapy of hypoxic-ischemic brain injury.
MENG Jun-Jie,LI Shi-Ping,ZHAO Feng-Yan et al. Effect of telomerase activation on biological behaviors of neural stem cells in rats with hypoxic-ischemic insults[J]. CJCP, 2017, 19(2): 229-236.
MENG Jun-Jie,LI Shi-Ping,ZHAO Feng-Yan et al. Effect of telomerase activation on biological behaviors of neural stem cells in rats with hypoxic-ischemic insults[J]. CJCP, 2017, 19(2): 229-236.
Ip FC,Ng YP,An HJ,et al.Cycloastragenol is a potent telomerase activator in neuronal cells:implications for depression management[J].Neurosignals,2014,22(1):52-63.
Zhao Y,Li Q,Zhao W,et al.Astragaloside IV and cycloastragenol are equally effective in inhibition of endoplasmic reticulum stress-associated TXNIP/NLRP3 inflammasome activation in the endothelium[J].J Ethnopharmacol,2015,169: 210-218.
[4]
Yung LY,Lam WS,Ho MK,et al.Astragaloside IV and cycloastragenol stimulate the phosphorylation of extracellular signal-regulated protein kinase in multiple cell types[J].Planta Med,2012,78(2):115-121.
[5]
Xu ME,Xiao SZ,Sun YH,et al.Effects of astragaloside IV on pathogenesis of metabolic syndrome in vitro[J].Acta Pharmacol Sin,2006,27(2):229-236.
[6]
Luo Y,Qin Z,Hong Z,et al.Astragaloside IV protects against ischemic brain injury in a murine model of transient focal ischemia[J].Neurosci Lett,2004,363(3):218-223.
[7]
Zhang WJ,Hufnagl P,Binder BR,et al.Antiinflammatory activity of astragaloside IV is mediated by inhibition of NFkappaB activation and adhesion molecule expression[J].Thromb Haemost,2003,90(5):904-914.
[8]
Sun J,Chen XL,Zheng JY,et al.Astragaloside IV protects new born rats from anesthesia-induced apoptosis in the developing brain[J].Exp Ther Med,2016,12(3):1829-1835.
[9]
Fauce SR,Jamieson BD,Chin AC,et al.Telomerase-based pharmacologic enhancement of antiviral function of human CD8+T lymphocytes[J].J Immunol,2008,181(10):7400-7406.
[10]
Li H,Babiarz J,Woodbury J,et al.Spatiotemporal heterogeneity of CNS radial glial cells and their transition to restricted precursors[J].Dev Biol,2004,271(2):225-238.
[11]
Castillo-Melendez M,Yawno T,Jenkin G,et al.Stem cell therapy to protect and repair the developing brain:a review of mechanisms of action of cord blood and amnion epithelial derived cells[J].Front Neurosci,2013,7:194.
[12]
Hsueh YY,Chang YJ,Huang CW,et al.Synergy of endothelial and neural progenitor cells from adipose-derived stem cells to preserve neurovascular structures in rat hypoxic-ischemic brain injury[J].Sci Rep,2015,5:14985.
[13]
Tajiri N,Acosta SA,Shahaduzzaman M,et al.Intravenous transplants of human adipose-derived stem cell protect the brain from traumatic brain injury-induced neurodegeneration and motor and cognitive impairments:cell graft biodistribution and soluble factors in young and aged rats[J].J Neurosci,2014, 34(1):313-326.
Li J,Qu Y,Chen D,et al.The neuroprotective role and mechanisms of TERT in neurons with oxygen-glucose deprivation[J].Neuroscience,2013,252:346-358.
[16]
Zhao F,Qu Y,Xiong T,et al.The neuroprotective role of TERT via an antiapoptotic mechanism in neonatal rats after hypoxiaischemia brain injury[J].Neurosci Lett,2012,515(1):39-43.
[17]
Liu Q,Sun Y,Lv Y,et al.TERT alleviates irradiation-induced late rectal injury by reducing hypoxia-induced ROS levels through the activation of NF-κB and autophagy[J].Int J Mol Med,2016,38(3):785-793.
[18]
Gutkin A,Uziel O,Beery E,et al.Tumor cells derived exosomes contain hTERT mRNA and transform nonmalignant fibroblasts into telomerase positive cells[J].Oncotarget,2016,7(37): 59173-59188.
